IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA

 

Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

 

Check Your Delivery Options

 
Rs. 3,651

Availability: In stock

 
  • Product Description
 

Imatinib mesylate is a novel drug which targets the molecular level in chronic myeloid leukaemia. The response rates in various studies were very impressive. There is no study of efficacy and adverse effects of imatinib mesylate in our local patients. It is generally believed that these would be similar to that of Western patients. However, physical and genetic differences may influence the effects of imatinib mesylate in Asian patients.

Product Specifications
SKU :COC22900
AuthorPing Chong Bee
LanguageEnglish
BindingPaperback
Number of Pages68
Publishing Year2010-08-04T00:00:00.000
ISBN978-3838355832
Edition1 st
Book TypeClinical & internal medicine
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-07-28 00:00:00
0 Review(s)